Brief: Bioretec Says FDA Approves Co's Remeos Trauma Screw As First Bioresorbable Metal Implant In U.S. Market
30/03/2023 05:19
March 30 (Reuters) - Bioretec Oy BRETEC.HE :
* FDA APPROVES BIORETEC'S REMEOS™ TRAUMA SCREW AS FIRST
BIORESORBABLE METAL IMPLANT IN U.S. MARKET
Source text for Eikon: ID:nWkrc8FkgG
Further company coverage: BRETEC.HE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million